Patents by Inventor Nathalie Wong

Nathalie Wong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD44 aptamer
    Patent number: 11807854
    Abstract: The present invention provides an aptamer that specifically hinds CD44, composition comprising the aptamer, as well as methods for detecting CD44 and for targeted delivery to CD44-expressing cells.
    Type: Grant
    Filed: March 14, 2022
    Date of Patent: November 7, 2023
    Assignee: The Chinese University of Hong Kong
    Inventors: Nathalie Wong, Wing Sze Lo, James Y.W. Lau
  • CD44 APTAMER
    Publication number: 20220364094
    Abstract: The present invention provides an aptamer that specifically hinds CD44, composition comprising the aptamer, as well as methods for detecting CD44 and for targeted delivery to CD44-expressing cells.
    Type: Application
    Filed: March 14, 2022
    Publication date: November 17, 2022
    Inventors: Nathalie WONG, Wing Sze Lo, James Y.W. Lau
  • METHODS OF TREATMENT OF HEPATOCELLULAR CARCINOMA
    Publication number: 20160374952
    Abstract: The present invention provides methods and compositions for treating hepatocellular carcinoma (HCC) by administering a composition comprising nanoparticles that comprise a taxane and an albumin. The invention also provides combination therapy methods of treating HCC comprising administering to an individual an effective amount of a composition comprising nanoparticles that comprise a taxane and an albumin and another agent, such as an agent that inhibits microtubule disassembly.
    Type: Application
    Filed: May 20, 2016
    Publication date: December 29, 2016
    Inventors: Winnie YEO, Nathalie WONG
  • Methods for treating hepatocellular carcinoma
    Patent number: 9370494
    Abstract: The present invention provides methods and compositions for treating hepatocellular carcinoma (HCC) by administering a composition comprising nanoparticles that comprise a taxane and an albumin. The invention also provides combination therapy methods of treating HCC comprising administering to an individual an effective amount of a composition comprising nanoparticles that comprise a taxane and an albumin and another agent, such as an agent that inhibits microtubule disassembly.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: June 21, 2016
    Assignee: ABRAXIS BIOSCIENCE, LLC
    Inventors: Winnie Yeo, Nathalie Wong
  • Detection of HBX/8P11 hybrid sequence in human hepatocellular carcinoma
    Patent number: 8680255
    Abstract: The present invention provides a method for diagnosing a particular type of human hepatocellular carcinoma (HCC), HBx/8p11-positive HCC, in a subject by detecting the presence of a specific, non-naturally occurring polynucleotide sequence that indicates integration of a portion of the human hepatitis B virus (HBV) sequence into the human genome on chromosome 8 in the 8p11 integration region. A kit and device useful for such a method are also provided. In addition, the present invention provides a method for treating an HBx/8p11-positive HCC.
    Type: Grant
    Filed: August 30, 2012
    Date of Patent: March 25, 2014
    Assignee: The Chinese University of Hong Kong
    Inventor: Nathalie Wong
  • METHODS FOR TREATING HEPATOCELLULAR CARCINOMA
    Publication number: 20140079787
    Abstract: The present invention provides methods and compositions for treating hepatocellular carcinoma (HCC) by administering a composition comprising nanoparticles that comprise a taxane and an albumin. The invention also provides combination therapy methods of treating HCC comprising administering to an individual an effective amount of a composition comprising nanoparticles that comprise a taxane and an albumin and another agent, such as an agent that inhibits microtubule disassembly.
    Type: Application
    Filed: February 28, 2013
    Publication date: March 20, 2014
    Applicant: ABRAXIS BIOSCIENCE, LLC
    Inventors: Winnie YEO, Nathalie WONG
  • METHODS FOR TREATING HEPATOCELLULAR CARCINOMA
    Publication number: 20130115296
    Abstract: The present invention provides methods and compositions for treating hepatocellular carcinoma (HCC) by administering a composition comprising nanoparticles that comprise a taxane and an albumin. The invention also provides combination therapy methods of treating HCC comprising administering to an individual an effective amount of a composition comprising nanoparticles that comprise a taxane and an albumin and another agent, such as an agent that inhibits microtubule disassembly.
    Type: Application
    Filed: March 25, 2011
    Publication date: May 9, 2013
    Inventors: Winnie Yeo, Nathalie Wong
  • DETECTION OF HBX/8P11 HYBRID SEQUENCE IN HUMAN HEPATOCELLULAR CARCINOMA
    Publication number: 20130072544
    Abstract: The present invention provides a method for diagnosing a particular type of human hepatocellular carcinoma (HCC), HBx/8p11-positive HCC, in a subject by detecting the presence of a specific, non-naturally occurring polynucleotide sequence that indicates integration of a portion of the human hepatitis B virus (HBV) sequence into the human genome on chromosome 8 in the 8p11 integration region. A kit and device useful for such a method are also provided. In addition, the present invention provides a method for treating an HBx/8p11-positive HCC.
    Type: Application
    Filed: August 30, 2012
    Publication date: March 21, 2013
    Applicant: The Chinese University of Hong Kong
    Inventor: Nathalie Wong